Takeda presents full data set from phase 3 advance-cidp 1 clinical trial investigating hyqvia® as a maintenance therapy for chronic inflammatory demyelinating polyneuropathy (cidp) at pns annual meeting

Osaka, japan & cambridge, mass.--(business wire)--full results from the phase 3 advance-cidp 1 clinical trial investigating hyqvia® as maintenance therapy in adults with cidp were presented at pns.
TAK Ratings Summary
TAK Quant Ranking